Trial Details
TERMINATEDBasic Information
| Clinical ID | c125 |
|---|---|
| Identifier | NCT02847052 |
| Trial Title | Study of the Role of Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding Protein (IL-22BP), in Chronic Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease |
| Interventions | OTHER: Non interventional study |
Participant Information
| Sponsor | Nantes University Hospital |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2025-08-14 |
|---|---|
| Primary Completion Date | 2022-03-16 |
| Completion Date | 2022-03-16 |